Welcoming EIT Health’s newest partners: kENUP Foundation and CRU

Partners in healthcare and innovtion

We are pleased to announce that our EIT Health InnoStarts network of partners is broadening with the addition of two new members this summer: kENUP Foundation and Clinical Research Units Hungary (CRU).

About kENUP:

kENUP is a not-for-profit organisation established in 2014 as a foundation in the Republic of Malta and now has a second office in Berlin, Germany. kENUP develops projects to pursue market-leading positions for European innovation businesses. In this capacity, kENUP is supporting the execution of the European Fund for Strategic Investments, the so-called “Juncker Plan”. kENUP supports its Partners in preparing their corporation or corporate programmes for an investment by the European Investment Bank (EIB), or by other public, private or venture investors.

kENUP supports business plans that have a clear potential for achieving global market leadership. In doing so, kENUP works with a network of distinguished research organisations from Europe, the United States and Israel, with large players in the private investment community, with SMEs and large corporations, as well with the relevant regulators, governmental bodies and Governments.

kENUP’s education branch focuses on digital programmes for educating global talent with low barriers to entry. These study courses encompass accredited degree programmes, as well as focused vocational trainings.

About CRU Clinical Research Units Hungary:

In July, CRU Clinical Research Units Hungary (CRU Hungary Ltd.) joined our InnoStars family.

CRU is a privately-owned Hospital-based Clinical Research Centre Network that specialises in conducting outpatient and inpatient clinical trials involving Pharmaceutical, Biological and Medical Device products.

CRU contracts with pharmaceutical companies and Contract Research Organisations to conduct clinical studies within their Departments in five different locations (three in Hungary, one in Ukraine and one in Vietnam). CRU extended its activities significantly in the recent years.

The core focus is still clinical research activity, but additional business areas were developed such us:

• Drug development
• eHealth technologies
• Biobanking
• Patient tourism
• Private Oncology Care
• Diagnostic services (radiology and molecular biology)
• Healthcare Infrastructure planning, development and investments
• Education projects, grants and investments

We look forward to working with our new partners and thank them for their interest in partnering with EIT Health.